BOOST Pharma
PrivateLast Round
Series A
Oct 8, 2026
Total Funding Raised
$6.71M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
BOOST Pharma is a clinical-stage biopharmaceutical company that develops novel mesenchymal stem cell therapies for the treatment of rare pediatric skeletal diseases, specifically osteogenesis imperfecta.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BOOST Pharma Comparables
Compare BOOST Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mereo BioPharma Group plc | 77% | |
| Ultragenyx Pharmaceutical Inc. | 71% | |
| AshiBio | 71% |
BOOST Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 8, 2026 | ||||
| Convertible Debt | Nov 3, 2025 | ||||
| Convertible Debt | Oct 28, 2025 | ||||
| Seed | May 28, 2024 | ||||
| Grant | Mar 1, 2021 | ||||
Debt | Feb 1, 2021 |
Key People
Founding team and executive leadership
BOOST Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Industrifonden | Convertible Debt, Seed |
| The Export and Investment Fund of Denmark | Debt |
| Karolinska Development AB | Convertible Debt, Seed |
| BioInnovation Institute | Pre Seed |
| Sound Bioventures | Convertible Debt |
| KDventures AB | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2026
$50M round completed.
- Apr 16, 2026
Grew 55% QoQ from 11 to 17 employees.
Recent news
Latest coverage and updates
- attends_eventSep 24, 2026
BOOST Pharma ApS will attend event Cell & Gene Meeting on Oct 7th '26.
- recognized_asSep 24, 2026
BOOST Pharma ApS will be recognized as 2026 Innovation Spotlight company at Cell & Gene Meeting on Oct 7th '26.
BOOST Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BOOST Pharma's valuation, stock price, and market status.
Is BOOST Pharma a public or private company?
BOOST Pharma is a private company.
What is the current stock price of BOOST Pharma?
BOOST Pharma is a private company, so its shares have no public market price. Caplight tracks BOOST Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BOOST Pharma worth (valuation)?
Valuation information for BOOST Pharma is not publicly available.
Can I buy BOOST Pharma stock?
BOOST Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BOOST Pharma's last funding round?
BOOST Pharma's most recent funding round was Series A on October 8, 2026.
Who are the main investors in BOOST Pharma?
Key investors in BOOST Pharma include BioInnovation Institute, Sound Bioventures.
Will BOOST Pharma IPO soon?
No public IPO plans have been announced for BOOST Pharma.
How can I track BOOST Pharma secondary market activity?
Caplight tracks bids, offers, and trades in BOOST Pharma's shares on secondary markets.